Skip to main content
Caplight Logo









InEdita Bio

InEdita Bio

Private
United StatesHealthcare & Life Scienceshttps://www.ineditabio.com/

Last Round

Grant

Aug 4, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

InEdita Bio is an agricultural biotechnology company that develops a proprietary genome editing platform using CRISPR technology to create non-transgenic crops with enhanced resistance to pests, diseases, and environmental stressors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

genome editingagtechgene silencingnon-transgenic cropsclimate-resilient cropsbiotechnologytrait developmentCRISPRseed technologybioinformaticsgene expressionagricultural innovationsynthetic biologyIP licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InEdita Bio Comparables

Compare InEdita Bio with similar companies based on industry and business-model similarity.

InEdita Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cibus, Inc.
83%
Phytoform Labs
83%
Hudson River Biotechnology
82%

InEdita Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 4, 2025
SeedAug 20, 2023

InEdita Bio Investors

Notable investors and investment history

InEdita Bio investors
InvestorRounds
Financiadora de Estudos e ProjetosGrant
Ecoa CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 72% MoM.

  • May 8, 2026

    Grew 25% QoQ, from 12 to 15 employees.

InEdita Bio Filings

Explore SEC and related filing metadata, where available.

InEdita Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InEdita Bio's valuation, stock price, and market status.

Is InEdita Bio a public or private company?

InEdita Bio is a private company.

What is the current stock price of InEdita Bio?

InEdita Bio is a private company with no public stock price. No recent secondary market data is available.

How much is InEdita Bio worth (valuation)?

Valuation information for InEdita Bio is not publicly available.

Can I buy InEdita Bio stock?

InEdita Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was InEdita Bio's last funding round?

InEdita Bio's most recent funding round was Grant on August 4, 2025.

Who are the main investors in InEdita Bio?

Key investors in InEdita Bio include Financiadora de Estudos e Projetos, Ecoa Capital.

Will InEdita Bio IPO soon?

No public IPO plans have been announced for InEdita Bio.

How can I track InEdita Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InEdita Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited States
Employee Range14
Year Founded2022
Last FundingAug 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?